Frontiers in Oncology | Neuro-Oncology and Neurosurgical Oncology

Original Research

Accepted on 29 Sep 2025

Tumor DNA from tumor in situ fluid was used to track evolution of glioma under first-line treatment

in Neuro-Oncology and Neurosurgical Oncology

Jinliang Yu
Yushuai Gao
Jiubing Zang
Dayang Wang
Kaiyuan Deng
Shuang Wu
Ziyue Zhang
Zhaoyue Yan
Guanzheng Liu
Liujian Dong

Frontiers in Oncology

doi 10.3389/fonc.2025.1581173

249 views

Original Research

Published on 29 Sep 2025

Mathematical modeling for glioblastoma treatment: scenario generation and validation for clinical patient counseling

in Neuro-Oncology and Neurosurgical Oncology

Eric J. Kostelich
Yuan Xu
Carlos Calderón-Valero
Duane C. Harris
Oscar Alcantar-Garibay
Gerardo Gomez-Castro
Thomas J. On
Richard D. Dortch
Yang Kuang
Mark C. Preul

Frontiers in Oncology

doi 10.3389/fonc.2025.1647144

1,739 views

Case Report

Published on 26 Sep 2025

A case report on IDH-mutant astrocytoma, CNS WHO grade 4: multi-omic characterization of untreated clinical progression

in Neuro-Oncology and Neurosurgical Oncology

Xiaoqin Tang
Wei Wei
Yanyan Huang
Yi Zheng
Yajing Xu
Fei Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1557245

976 views

Editorial

Published on 25 Sep 2025

Editorial: Advancing precision therapies in glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Theophilos Tzaridis
Marike Broekman
Konstantinos Gousias

Frontiers in Oncology

doi 10.3389/fonc.2025.1681786

1,551 views

Systematic Review

Published on 25 Sep 2025

Scientometric analysis of glioblastoma and blood-brain barrier research (1995−2024): evolving trends and therapeutic challenges

in Neuro-Oncology and Neurosurgical Oncology

Xuan-Hao Pan
Nan Wang
Yi-Chun He
Jing Su
Yu-Fei Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1649414

687 views

Review

Published on 25 Sep 2025

Sleep disturbances in brain tumors: a narrative review

in Neuro-Oncology and Neurosurgical Oncology

Qiang Liang
Tianyi Hu
Tong Yang
Yawen Pan
Karen Spruyt
Xinyan Zhang
Qiang Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1594232

738 views

Original Research

Published on 23 Sep 2025

XPO1-inhibitor Selinexor induces MGMT expression by activating PKA-CREB signaling in IDH wildtype glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Josephine A. Mapunda
Yuta Suzuki
Danielle Burgenske
Paul A. Decker
Lin Zhang
Jeanette E. Eckel-Passow
Jann N. Sarkaria
Gaspar J. Kitange

Frontiers in Oncology

doi 10.3389/fonc.2025.1633580

781 views

Original Research

Accepted on 22 Sep 2025

An Implantable, Intracerebral Osmotic Pump for Convection-Enhanced Drug Delivery in Glioblastoma Multiforme

in Neuro-Oncology and Neurosurgical Oncology

Reed Berlet
Azur Azapagic
Neilank K Jha
Daniil Aksenov
Jade Bookwalter
Ata Ullah
George Bobustuc
John Lee
Himanshu Sant
John McDaid

Frontiers in Oncology

doi 10.3389/fonc.2025.1676691

339 views

Systematic Review

Accepted on 22 Sep 2025

A Scientometric Analysis of Global Research on Gut Microbiota and Glioma

in Neuro-Oncology and Neurosurgical Oncology

Lize Chen
Kun Shu
Zhiyin Zhang
Jiao Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1646187

310 views

Case Report

Published on 22 Sep 2025

Case Report: Hypothalamic demyelinating lesion preceding lymphoma arising outside the central nervous system

in Neuro-Oncology and Neurosurgical Oncology

Narushi Sugii
Hiroyoshi Kino
Tetsu Suzuki
Noriaki Sakamoto
Makoto Shibuya
Ken Akimoto
Masahide Matsuda
Eiichi Ishikawa

Frontiers in Oncology

doi 10.3389/fonc.2025.1553142

924 views

Original Research

Published on 22 Sep 2025

Characterization of hypoxia-related molecular clusters and prognostic riskScore for glioma

in Neuro-Oncology and Neurosurgical Oncology

Xiang Fang
Xinhao Wu
Chengran Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1605949

2,204 views

Original Research

Accepted on 18 Sep 2025

Clinical characteristics and analysis of cerebrospinal fluid biochemical, tumor markers and cytologic indices in 209 patients with meningeal carcinomatosis: a cross-sectional study

in Neuro-Oncology and Neurosurgical Oncology

Shaoqiang Xu
Chunxia Huang
Yuangyang Ye
Keyuan Lai
sihan Lan
Zihan Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1594662

581 views

Original Research

Published on 16 Sep 2025

Histopathological grading affects survival in patients with isocitrate dehydrogenase-wildtype gliomas

in Neuro-Oncology and Neurosurgical Oncology

Ziming Hou
Dongyuan Liu
Zhe Hou
Hongbing Zhang
Hao Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1570941

2,040 views

Review

Published on 11 Sep 2025

Glioma-neuron interactions: insights from neural plasticity

in Neuro-Oncology and Neurosurgical Oncology

Jingyu Feng
Jun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1661897

1,225 views

Original Research

Published on 11 Sep 2025

GADD45G as a novel prognostic biomarker and therapeutic target in glioma: integrative analysis of bulk and single-cell RNA sequencing

in Neuro-Oncology and Neurosurgical Oncology

Cong Shen
Haiping Cai
Chengliang Mao
Jiahao Yang
Kai Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1608710

1,152 views

Original Research

Published on 10 Sep 2025

Age is not a significant predictor of survival in patients with IDH-wildtype glioblastoma that undergo gross total resection and complete adjuvant chemoradiation

in Neuro-Oncology and Neurosurgical Oncology

Jeffrey W. Cozzens
Noah B. Drewes
Kristin R. Delfino
Kayla L. Chin
Devin V. Amin
Barbara C. Lokaitis
José A. Espinosa
Breck A. Jones
Leslie J. Acakpo-Satchivi
Hayan Dayoub

Frontiers in Oncology

doi 10.3389/fonc.2025.1657867

991 views